
A recent Senate hearing on conflicts of interest (COIs) in medical education and research revealed that the tri-committee health care reform bill requires public disclosure of pharmaceutical company payments to several health entities, that the removal of industry-sponsored symposia by the American Psychiatric Association (APA) cost it $1.5 million in revenues, and that the Accreditation Council for Continuing Medical Education (ACCME) is expanding its requirements and enforcement actions.
